![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/00 | |
A61K 9/08 | |||
A61K 38/29 | |||
A61P 19/10 |
(11) | Number of the document | 2073789 |
(13) | Kind of document | T |
(96) | European patent application number | 07870768.4 |
Date of filing the European patent application | 2007-10-03 | |
(97) | Date of publication of the European application | 2009-07-01 |
(45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/021216 |
Date | 2007-10-03 |
(87) | Number | WO 2008/063279 |
Date | 2008-05-29 |
(30) | Number | Date | Country code |
848960 P | 2006-10-03 | US |
(72) |
DEY, Michael J., GB
MONDOLY, Nathalie, FR
RIGAUD, Benedicte, FR
HENDERSON, Bart, US
LYTTLE, C. Richard, US
|
(73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
Radius Health, Inc., 950 Winter Street, Waltham, MA 02451, US |
(54) | A STABLE COMPOSITION COMPRISING A BONE ANABOLIC PROTEIN, NAMELY A PTHRP ANALOGUE, AND USES THEREOF |
A STABLE COMPOSITION COMPRISING A BONE ANABOLIC PROTEIN, NAMELY A PTHRP ANALOGUE, AND USES THEREOF |